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Perfluoroalkyl substances (PFASs) and organochlorines (OCs) are ubiquitous and persis-
tent in the environment and proposed endocrine disrupting chemicals (EDCs). They can be
transferred across the placenta during pregnancy, and studies suggest that the prenatal
period may be particularly sensitive for influences on fetal growth and development. Sev-
eral studies have investigated socio-demographic and pregnancy related factors associ-
ated with maternal serum PFAS and OC levels, but few studies have been conducted in
time periods with increasing emissions of PFASs and recent emissions of OCs.
Methods
Serum from 424 pregnant women participating in the NICHD Scandinavian Successive
Small-for-gestational Age (SGA) births study was collected in 1986–1988, and analyses of
two PFASs and six OCs were conducted. Associations between EDCs and geographic,
time dependent, socio-demographic and pregnancy related variables were evaluated by
using multivariable linear regression models.
Results
Previous breastfeeding duration, time since last breastfeeding period, sampling date and
country of residence were important factors associated with serum levels of PFOS and
PFOA. Smoking status and pre-pregnancy BMI were negatively associated with PFOS,
and maternal height was borderline negatively associated with PFOS and PFOA. Glomeru-
lar filtration rate (GFR) was negatively associated with PFOS in a sub-sample. Maternal
serum levels of OCs were positively associated with maternal age, and negatively
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associated with previous breastfeeding duration and sampling date. Smoking had a consis-
tently negative association with PCB 118 in a dose-dependent manner. Education level,
pre-pregnancy BMI and alcohol consumption varied in importance according to the com-
pound under study.
Conclusions
Several maternal factors, including potentially modifiable factors, markers of pregnancy
physiology and factors also related to perinatal outcomes were associated with EDC levels.
Results from this study are relevant to populations with still high PFAS and OC levels, i.e.
developing countries. Moreover, we can use this knowledge about associated factors on
emerging EDCs with similar properties.
Introduction
Perfluoroalkyl substances (PFASs) are synthetic chemicals that have been widely used in con-
sumer products including lubricants, paper products and textiles since the 1950s [1]. Numer-
ous PFASs are persistent substances, with approximate human half-lives of 2–5 years [2].
Organochlorines (OCs) comprise several substances, including polychlorinated biphenyls
(PCBs) and pesticides. PCBs have been produced for commercial use in paints, plastics and
electrical transformer fluids, whereas pesticides were used to control pests and disease [3].
PFASs are proteinophilic, primarily bound to albumin in serum and reside in blood, liver and
kidneys [4], whereas OCs are lipid soluble and accumulate in fatty tissues [5]. PFASs and OCs
can cross the placental barrier [6, 7], and in utero exposure have been associated with adverse
effects of growth and development in both animal and epidemiological studies [8–10]. These
environmental pollutants have been categorized as endocrine disruptive chemicals (EDCs) due
to their disruption in the regulation of estrogen and thyroid hormones [11, 12]. In 2012, a
report from the United Nations Environment Programme (UNEP) and theWorld Health
Organization (WHO) identified EDCs as an emerging health challenge to vulnerable individu-
als in society, particularly fetuses and children [13]. Maternal serumEDC levels are relevant
biomarkers of fetal exposure.
There are large inter-individual differences in maternal serum levels of EDCs, but reasons
behind the large variation have not been consistent. A better understanding of factors associ-
ated with serum levels of EDCs would improve the basis for advices with the purpose to lower
the body burdens of young women during pregnancy. This knowledgemay also provide infor-
mation regarding exposure routes in addition to distribution and elimination of EDCs in the
body.
Most previous studies on factors associated with PFAS and OC levels were conducted in
post-ban periodswhen contaminant levels were declining in most Western countries. Impor-
tant sources of exposures and associatedmaternal factors will change over time as emission his-
tory is changing. New knowledge about associated factors in historical periods of increasing
PFAS emissions and recent OC emissions is important because biomonitoring studies have
revealedminimal temporal declines and even increases in PFAS and OC levels among some
populations, i.e. some developing countries [3, 14]. Moreover, we can use this knowledge about
associated factors on new emerging EDCs with similar properties. Although epidemiologic
studies have reported associations betweenmaternal serum levels of PFASs and OCs and
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indices of fetal growth [15, 16], potential confounders of these associations are not consistently
reported and important to examine. This descriptive study of Scandinavian parous women
examines factors associated with maternal serum levels of PFASs and OCs from years of con-
tinued emissions of PFASs and recent emissions of OCs (1986–1988) [17].
Materials and Methods
Ethics statement
All participants provided written informed consent for continued use of data and biomaterial,
which was documented at the first study visit. The study, including the consent procedure, has
been reviewed and approved by the Central Norway Regional Committee for Medical and
Health Sciences Research Ethics (REKMidt 2010/1449-5).
Study area and population
Participants were from the NICHD Scandinavian Successive Small- for- Gestational Age
(SGA) births study; a population based prospectivemulticenter study conducted in Trondheim
and Bergen (Norway) and Uppsala (Sweden) (1986–1988) [17]. The SGA births study was
designed to study the etiology and consequences of intrauterine growth restriction. Eligible
participants included para 1 and para 2 women of Caucasian origin who spoke one of the Scan-
dinavian languages and had a singleton pregnancy. In total, 5,722 women were eligible and
made the first appointment, from which three groups were defined: a 10% random sample
(n = 561); a group at high risk for SGA birth (n = 1,384), and a rest of population group
(n = 3,777). Both the random sample and high risk groups were included for detailed follow-
up. The high risk for SGA birth group was defined by one or more of the following risk factors:
a) a prior low birth weight (LBW) child, b) maternal cigarette smoking at conception, c) low
pre-pregnancy weight (<50 kg), d) a previous perinatal death, or 5) the presence of chronic
maternal disease. Serum samples from n = 424 mothers were randomly selected for PFAS and
OC analyses including a 2:1 ratio of non-SGA births to SGA births for future analysis (Fig 1).
Data on maternal characteristics
Data on socio-demographics, bodymass index (BMI), lifestyle variables, and previous obstetric
history were collected at first study visit. Socio-demographicvariables includedmaternal age
(continuous; years) and level of education (ordinal; 5 levels from low to high). Body weight and
height were reported and pre-pregnancy BMI was calculated as weight in kilograms divided by
height in meters squared (continuous; kg/m2). Lifestyle variables included smoking status at
conception (categorical; smokers or non-smokers), number of cigarettes smoked at conception
and in 2nd trimester, and alcohol consumption during pregnancy (ordinal; 5 levels from low to
high). Smokers were women who at first study visit reported daily smoking at the time of con-
ception. Obstetric variables included parity (binary; 1 or 2), previous breastfeeding duration
(continuous; months) and time since end of last breastfeeding period (continuous; per year).
We categorized serum collection by sampling date (continuous; for each 100 days since study
inception) and gestational age at serum sampling (completed weeks).
Measurement of PFAS and OCs
Maternal serum samples were collected during the 2nd trimester at approximately week 17
(Table 1), and stored at -80°C for later analysis. In total, a random selection of n = 424 serum
samples were included for PFAS and OC analyses (Fig 1).
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Chemical analyses of PFAS. Analyses were performed at the laboratories of Norwegian
Institute for Air Research, Tromsø, Norway (NILU). PFASs measured were perfluorooctanoate
(PFOA) and perfluorooctanesulfonate (PFOS). Samples were analyzed using sonication-facili-
tated liquid-liquid extraction, activated ENVI-carb clean-up [18], quantified and analyzed by
ultrahigh pressure liquid chromatography triple-quadrupolemass-spectrometry (UHPLC-MS/
MS).
Sample preparation and extractionwere performed as describedby Hanssen et. al [19]
except for minor volume changes.
The quantification was conducted with the LC Quan software, version 2.6.0 (Thermo Fisher
Scientific Inc, Waltham, MA, USA). The internal-standard addition method with isotope-
labeled PFASs was used to quantify the contaminants [19]. Concentrations of PFASs in all
samples were within the linear range of the instrument and the calibration curve. In the mass
spectrometry analyses, a secondmass transition served to confirm compound specificity for
each compound. The quality of the analysis was verified by repetitive analysis of blank samples
and reference samples (SRM 1957, NIS, Gaithersburg, MD, USA). Participation in the AMAP
ring test program and results from SRMmaterial indicates a coefficient of variation (CV) of
15% for PFOA and 10% for PFOS. The linear PFOS isomers were chromatographically
Fig 1. Flow chart of the participant selection for PFAS and OC analysis. 1From 10% random sample.2From High-risk group.
doi:10.1371/journal.pone.0166127.g001
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separated from the branched isomers and quantified separately. Unless otherwise specified, the
PFOS results discussed are the sum of linear and branched isomers.
Chemical analyses of OCs. OCswere analyzed using the POPs method E-446 (ISO 1 7025
accreditation) at the Institut National de Santé Publique du Quebec,Centre Toxicologie, Que-
bec. This laboratory is the organizer of the AMAP ring program. OCsmeasured were hexa-
chlorobenzene (HCB), oxychlordane, PCB 52, PCB 101, PCB 118, PCB 153, PCB 156, PCB
170, PCB 180, p,p’-dichlorodiphenyldichloroehylene (p,p’-DDE), p,p’-dichlorophenyltrichlor-
oethane (p,p’-DDT), beta-hexachlorohexane (β-HCH) and trans-nonachlor (t-NC). Only OCs
detected in more than 99% of the samples and used in the regression analyses were included in
Table 1. Because of high correlation between PCBs we chose to use and report PCB 118,
Table 1. Maternal characteristics of the current sample of Scandinavian parous pregnant women in
the SGA-study (N = 424).
% or mean (range)
Gestational age1 at serum sampling 17 (13–20)
Sampling date 1986 41.2%
1987 49.8%
1988 7.8%
Country of residence Norway 62.5%
Sweden 37.5%
Maternal age (years) 29.0 (18–41)
Maternal height (cm) 166 (150–182)
Maternal pre-pregnancy BMI (kg/m2) 21.5 (16–33)






Higher education, university level 8.0%
Parity 1 68.9%
2 31.1%
Smoking at conception No 54.5%
Yes 45.5%
Number of cigarettes per day at conception 5.4 (0–25)
Smoking in early 2nd trimester No 58.7%
Yes 40.1%
Number of cigarettes per day at 2nd trimester 4.1 (0–25)
Alcohol consumption during pregnancy2 Never 47.4%
< once a month 33.7%
About once every month 9.2%
2–3 times per month 4.7%
 once a week 1.9%
Previous breastfeeding duration (months) 7.4 (0–24)





1Gestational age based on ultrasound measurements (completed weeks)
2Infomation collected in week 33 of pregnancy
doi:10.1371/journal.pone.0166127.t001
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representing dioxin-like PCBs and PCB 153, representing non-dioxin like PCBs. In short, 0.5–
1 ml serum sample was extracted using hexane (2x6 ml), ethanol (2 ml) and saturated ammo-
nium sulphate solution (2 ml). This method is a slight modification of the one describedby
Sandanger et al. [20], where the samples were cleaned up using 1 g of activated fluorisil on an
automated Liquid handler system before GC-MS analysis described by Sandanger et al. [21].
Results from the AMAP ring test program and SRMmaterial indicate a CV of 5–10% for the
OCs analyzed.
Statistical analyses
The distribution of PFAS and OC levels closely followed a log-normal distribution.We there-
fore transformed data accordingly. We used wet weight concentrations of PFASs and lipid-
adjusted serum concentrations of OCs [22]. As a sensitivity analysis we used wet weight values
of OCs and adjusted for total lipids as an independent variable, but neither point estimates nor
95% confidence intervals (95% CIs) showed considerable change (data not shown).
Total lipid values were calculated based on measurements of triglycerides and cholesterol:
total lipids = 1.33triglycerides + 1.12cholesterol + 1.48 (g/l) [22]. This formula showed good
correlation with complete formulas including phospholipids [23].
We usedmultivariable linear regression to estimate associations betweenmaternal charac-
teristics and serumPFAS (PFOA and PFOS) and OC (PCB 118, PCB 153, p,p’-DDE, t-NC,
HCB and β-HCH) levels, and reported adjusted estimates and 95% confidence intervals (CIs).
Based on a priori knowledge, the following co-variates were included in adjusted analyses:
serum sampling date, study site (Norway/Sweden), maternal age, education level, maternal
height and pre-pregnancy bodymass index (BMI), smoking status at conception, alcohol con-
sumption during pregnancy, parity (1 vs. 2), previous breastfeeding duration and time since
end of last breastfeeding period.We evaluated linear model assumptions using diagnostic plots
of the residuals and checked the covariates for multicollinearity by variance inflation factors
(VIFs).We calculated percent change in PFAS and OC levels for each independent variable by
exponentiating regression coefficients, subtracting 1 and multiplying by 100.
In sub-analyses we investigated potential dose-response relationships between smoking
intensity (number of cigarettes smoked at conception and in early 2nd trimester) and levels of
PFOS, PCB 118 and β-HCH. As a sensitivity analysis we used serum cotinine levels measured
from samples collected at first study visit available from n = 88 women to further examine the
association between smoking and PFOS, PCB 118 and β-HCH levels.
As markers of pregnancy physiology we examined glomerular filtration rate (GFR) in
n = 88 of the samples. We calculated GFR (mL/min per 1.73 m2) using the Cockroft-Gault
(GFR-CG) formula (GFR-CG = (140-age) x weight (g) x 1.04/serumcreatinine (μmol/L)).




Maternal baseline characteristics are presented in Table 1. The gestational age at serum sam-
pling varied from 13 to 20 weeks, with a mean gestation age of 17 weeks. A larger proportion of
participants came from Norway (63%), while the majority of participants were pregnant with
their second child (69%). Nearly half of all participants reported smoking at conception (46%),
with a slight reduction by first visit in early 2nd trimester (40% smokers). In gestational week
33, more than half of all study participants reported at least some alcohol consumption (47%
no alcohol).
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PLOS ONE | DOI:10.1371/journal.pone.0166127 November 8, 2016 6 / 17
Serum PFAS and OC levels
Serum levels of two PFASs (PFOA and PFOS) and six OCs are presented in Table 2. All PFASs
and OCs reported were detected in 100% of the samples, with the exception of β-HCH levels
which were detected in 99% of the samples. In wet weight values, PFOS was the dominating
compound, followed by PFOA, p,p’-DDE, PCB 153, β-HCH, HCB, PCB 118 and t-NC.
Maternal factors associated with PFAS and OC levels
PFASs. In adjusted analyses, Swedish women had 39% higher PFOA levels and 67%
higher PFOS levels compared to their Norwegian peers. Previous breastfeeding duration was
negatively associated, while time since last breastfeeding periodwas positively associated with
PFOA and PFOS. An increase in both PFOA and PFOS per 100 days from study enrollment
was observed (2.8% and 5.0% respectively). Smokers had on average 21% lower levels of PFOS
than non-smokers (Table 3), and in sensitivity analyses, we found a linear relationship between
increasing number of cigarettes smoked at conception (p = 0.015) and in early 2nd trimester
(p = 0.006) and decreasing PFOS levels (Table 4). However, this finding was not replicated in a
sensitivity analyses of n = 88 women with available cotinine levels from 2nd trimester (p =
0.113) (Table 4). Adjusted for maternal height, pre-pregnancy BMI and gestational age at
serum sampling, GFR was negatively associated with PFOS in the same sub-sample (n = 88)
(Table 5). Pre-pregnancy BMI was negatively associated with PFOS levels in multivariable lin-
ear regression model (Table 3).
OCs. In adjusted analyses, Swedish women had, on average, 43% higher levels of PCB 153
and 9% lower levels of t-NC than Norwegian women. All OC levels, except PCB 118 and t-NC,
decreased from January 1986 throughMarch 1988. Previous breastfeeding duration was nega-
tively associated and maternal age positively associated with all OCs (Table 3). Pre-pregnancy
BMI was negatively associated with PCB 153 and t-NC.Women who smoked at conception
had on average 26% lower levels of PCB 118 and 9% higher levels of β-HCH, compared to non-
smokers. In sensitivity analyses, we found a clear dose-response relationship between increas-
ing number of cigarettes smoked both at conception and (p<0.001) and in early 2nd trimester
(p<0.001) and decreasing PCB 118 levels (Table 4). This finding was confirmed in a sub-sam-
ple analysis of the n = 88 women with available serum cotinine levels (p = 0.004). We also
found some evidence of a positive linear relationship between cigarettes smoked at conception
and in 2nd trimester and β-HCH levels, but this could not be confirmedwith cotinine levels
Table 2. Maternal serum levels of PFASs (ng/ml) and OCs (ng/ml and ng/g lipids) in the SGA study
(N = 424).
Wet weight (ng/ml) Lipid weight (ng/g lipid) LOD1 %>LOD2
Median (range)
PFOA 1.82 (0.31–7.97) - 0.03 100
PFOS 12.3 (0.95–59.6) - 0.03 100
PCB 118 0.08 (0.03–0.27) 13.9 (5.38–86.2) 0.01 100
PCB 153 0.52 (0.17–1.40) 89.9 (31.0–212) 0.01 100
p,p’-DDE 1.30 (0.10–11.0) 223 (16.7–1791) 0.09 100
HCB 0.10 (0.04–0.38) 17.7 (6.98–73.0) 0.04 100
β-HCH 0.13 (<LOD-0.76) 22.1 (<LOD-134) 0.01 99
t-NC 0.04 (0.01–0.14) 6.51 (1.82–25.2) 0.01 100
1LOD: Limit of detection (ng/ml)
2%>LOD: percentage of samples in which the analyte was detected
doi:10.1371/journal.pone.0166127.t002
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(p = 0.428). Increased length of education was significantly associated with increased p,p’-
DDE, t-NC, and β-HCH levels, and alcohol consumption during pregnancy was positively
associated with serumPCB153, t-NC and HCB levels (Table 3).
Discussion
In this descriptive study of n = 424 Scandinavian parous women, Swedish women had higher
levels of PFOS, PFOA and PCB 153 levels compared to Norwegian ones. Our results indicate
that several maternal factors, including potentially modifiable lifestyle factors, are indepen-
dently associated with maternal serumEDC levels.We demonstrated that long previous breast-
feeding duration was associated with lower PFAS and OC levels, and that long time since last
breastfeeding periodwas associated with higher PFAS levels. Maternal smoking showed a con-
sistently negative association with PCB 118 in a dose-dependentmanner.
Table 3. Adjusted1 associations from multivariable linear regression models for sociodemographic and pregnancy-related variables and ln-
transformed maternal PFAS (ng/ml) and OC levels (ng/g lipids) in serum collected in 2nd trimester (n = 424).
Ln (PFAS (ng/ml)) Ln (OC (ng/g lipid))






























Norway ref. ref. ref. ref. ref. ref. ref. ref.
Sweden 39 (27, 53) 67 (49, 88) 8.0 (-0.7, 17) 43 (35, 52) 2.0 (-11, 16) -2.5 (-8.7,
4.2)
7.4 (-0.5, 16) -9.4 (-16,
-1.7)




5.6 (-1.1, 13) 1.1 (-3.4, 5.9) 10 (-0.6, 22) 1.9 (-3.3, 7.3) 0.1 (-5.7, 6.2) 1.1 (-5.2, 7.7)












1.0 (-0.3, 2.4) -2.0 (-3.4,
-0.6)




2.5 (1.2, 3.8) 2.9 (2.0, 3.8) 5.5 (3.5, 7.6) 2.6 (1.6, 3.7) 3.2 (2.0, 4.4) 3.5 (2.3, 4.8)
Smoking at conception





-26 (-38, -16) 0.9 (-5.3, 6.6) 3.0 (-11, 15) -4.4 (-12,
2.5)
9.2 (1.9, 16) 7.0 (-1.1, 14)
Alcohol consumption (5
groups from low to high)3
0.6 (-4.2, 5.5) -0.4 (-6.2,
5.8)
5.1 (0.8, 9.7) 3.5 (0.4, 6.6) 3.3 (-3.2, 10) 3.2 (-0.2, 6.8) 2.5 (-1.3, 6.6) 5.6 (1.3, 10)
Education level (5 groups
from low to high)2
2.0 (-2.4, 6.6) 3.0 (-2.5, 8.7) 2.3 (-1.6, 6.3) 1.6 (-1.1, 4.4) 7.0 (0.9, 14) 1.4 (-1.7, 4.6) 3.3 (-0.3, 7.0) 4.8 (0.9, 8.8)
Parity



































0.2 (-1.2, 1.7) -0.01 (-1.6,
1.6)
1Multivariable models were adjusted for all variables included in the table.
2Education level (ordinal): 1 = <9 years, 2 = 9–11 years, 3 = 12 years, 4 = higher education, non-university level, 5 = higher education, university level.
3Alcohol consumption during pregnancy (ordinal): 0 = never, 1 = <once a month, 2 = once a month, 3 = 2–3 times a month, 4 = >once a week.
doi:10.1371/journal.pone.0166127.t003
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Serum levels of PFASs and OCs; sampling date and geographic factors
Bothmaternal PFAS and OC levels found in our study were lower than levels among a group
of Danish pregnant women sampled in 1988–1989 [24]. PCB levels were slightly lower than
levels among women from the Netherlands (1990–1992) [25] and higher than levels among
Swedish primiparous women enrolled in 1996–1999 [26]. Our study, conducted in 1986–1988,
had only parous women that may have led to lower levels of PFASs and OCs due to elimination
through the placenta and breast milk in earlier pregnancies.
The increase in PFAS levels over time (i.e. from January 1986 to March 1988) is consistent
with other studies showing a rise in PFOA and PFOS levels from the 1960s to around 2000,
and a subsequent decrease thereafter [27–29]. In contrast, almost all OC levels declined from
January 1986, which is consistent with findings from longitudinal studies that observed a
declining trend of most OCs after 1986 [30–32]. These changes compare with trends of historic
production, restrictions, and use and bans on use of PFASs and OCs, leading to declining levels
of these toxicants in air and biota [3].
Table 4. Adjusted1 associations from multivariable linear regression models between smoking intensity and ln-transformed maternal PFOS,
PCB 118 and β-HCH levels in serum collected in 2nd trimester (n = 424).
PFOS PCB 118 β-HCH
% change (95% CI) p-value % change (95% CI) p-value % change (95% CI) p-value
Smoking status at conception
no smoking ref. ref. ref.
1–5 cig/day -11 (-29, 11) 0.292 -14 (-23, -4.9) 0.004 1.1 (-12, 16) 0.876
6–10 cig/day -9.1 (-21, 4.1) 0.166 -20 (-25, -14) <0.001 13 (4.3, 23) 0.003
>10 cig/day -15 (-26, -2.7) 0.019 -24 (-29, -19) <0.001 13 (3.7, 23) 0.005
p for trend 0.015 <0.001 0.001
Smoking status at week 17
no smoking ref. ref. ref.
1–5 cig/day -7.7 (-23, 11) 0.384 -21 (-28, -15) <0.001 1.1 (-10, 13) 0.845
6–10 cig/day -17 (-28, -4.5) 0.010 -23 (-28, -18) <0.001 15 (5.9, 26) 0.001
>10 cig/day -13 (-26, 1.9) 0.084 -25 (-31, -20) <0.001 6.9 (-2.9, 18) 0.173
p for trend 0.006 <0.001 0.010
Serum cotinine levels at 2nd trimester2 -2.0 (-4.5, 0.5) 0.113 -1.8 (-3.0, -0.6) 0.004 0.8 (-1.1, 2.7) 0.428
1Adjusted for maternal pre-pregnancy BMI, country of residence and maternal PCB 153-levels.
2Only analyzed for a subset of 88 women. Numbers shown are percent change in POPs levels for each 100-unit increase in serum cotinine (range 0–1856).
doi:10.1371/journal.pone.0166127.t004
Table 5. Adjusted associations from multivariable regression models between GFR, maternal height and pre-pregnancy BMI, and ln-transformed
maternal PFOA and PFOS levels in serum collected in 2nd trimester from a subset of n = 88 mothers.
PFOA PFOS
Without GFR2 With GFR3 Without GFR With GFR
% change (95% CI) % change (95% CI) % change (95% CI) % change (95% CI)
GFR (per 10 ml/min per 1.73 m2)1 - 2.6 (-7.6, 2.8) - -8.6 (-15, -2.3)
Maternal height (per 10 cm) -12 (-24, 3.2) -9.0 (-23, 7.3) -19 (-33, -0.7) -10 (-27, 10)
Maternal BMI (per kg/m2) 0.2 (-3.2, 3.6) 1.6 (-2.9, 6.3) 2.1 (-2.3, 6.6) 7.4 (1.5, 14)
1Mutually adjusted estimates, in addition to adjustment for gestational age at serum sampling.
2Analyses performed without adjustment for GFR.
3Analyses performed with adjustment for GFR.
doi:10.1371/journal.pone.0166127.t005
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Higher levels of PCBs among Swedish women seem reasonable and correspond to higher
levels reported in fish from the Baltic Sea [33, 34]. Dietary intake is probably also the most
important exposure source to PFASs [35], and particularly seafood in Scandinavian countries
[36]. However, other sources of exposure such as drinkingwater and dust may contribute to
variability in levels between the study sites, particularly in time periodswith continued use and
emissions [35, 37].
Despite declining serum levels of PFASs and OCs in mostWestern countries, biomonitoring
programs still demonstrate high levels of both PFASs and OCs among certain populations and
countries today [3]. So, this study may be of great importance to certain populations with still
high environmental levels of PFASs and OCs, i.e. developing countries [14].
Maternal socio-demographic and pregnancy related factors associated
with PFAS levels
Our results emphasize that information on previous breastfeeding duration is important in the
evaluation of PFAS levels in women. The negative linear association between breastfeeding
duration and PFAS levels is also consistent with other studies [38, 39]. Due to the placenta bar-
rier, elimination through breast milk is thought to be greater than the prenatal transfer to the
fetus [40]. Several studies from post-ban periods (after year 2000) have found parity as an
important predictor of PFAS levels [41]. The null association between parity and PFAS levels
in the current study is in line with a study from the pre-ban period (1978–2001) when parity
was not identified as a predictor of PFOS levels [42]. This suggests that the relative importance
of parity as a predictor differs between pre- and post-ban periods.We found the same null
association between parity and PFAS levels when we excluded breastfeeding duration from the
multivariable models (data not shown). We also included time since last breastfeeding period
in the analyses because the importance of parity likely depends on how recent the previous
pregnancy was.
PFASs have the potential to bio-accumulate, and we hypothesize that non-pregnant peri-
ods without breastfeeding are important accumulation periods for women of fertile age. The
positive association between PFAS levels and time since last breastfeeding period in the cur-
rent study is consistent with a Norwegian study of pregnant women sampled in 2003 that
also showed a rise in PFAS levels during pregnancy intervals [38]. Long intervals between
two subsequent pregnancies have been associated with adverse perinatal outcomes [43], thus,
it is important to consider that time period as a potential confounder in child health effect
studies.
The lower levels of PFOS among women who smoked at conception were confirmed in
additional analyses where increasing number of cigarettes smoked at conception and in early
2nd trimester were associated with decreasing levels of PFOS. However, the non-linear relation-
ship between serum cotinine and PFOS levels corresponds to other studies that found inconsis-
tent associations with smoking overall, and no associations with smoking intensity [38, 44].
This suggests that the relationship between smoking and PFOS levels may be explained by dif-
ferent lifestyle patterns (e.g. diet) among smokers and non-smokers.
Only one other study has examined associations betweenGFR and PFASs among pregnant
women [45], and like that study, we found an inverse association betweenGFR and PFOS
(p = 0.002) in a sub-sample (n = 88). GFR describes the flow rate of filtered fluid through the
kidney, and we postulate that higher GFR leads to more excretion of PFASs and thereby lower
serum levels of PFASs. Because studies have indicated a possible association betweenGFR and
infant birth weight [46], GFRmight be considered a potential confounder in epidemiologic
studies of PFASs and fetal growth. In fact, a recent study that examined the impact of GFR on
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associations between PFASs and birth weight, suggested that associations were largely attenu-
ated due to confounding by GFR [47].
The weak negative association we observed between pre-pregnancy BMI and PFOS is in
contrast to other studies that reported positive [7, 38, 45] or null associations [42, 48]. This
finding, together with the negative association betweenmaternal height and PFAS levels, is
not completely understood, but may be due to proposed poorer plasma volume expansion,
leading to higher PFAS levels, among smaller sized women [49]. BMI was not associated
with maternal height in our study, but lack of adjustment for GFR might give biased results
in the multivariate models. GFR is positively related to maternal height and weight. In a sen-
sitivity analysis (n = 88), we estimated the associations betweenGFR, maternal height and
BMI and PFAS levels. When we included GFR in the model, the negative association between
maternal height and PFOS attenuated and the association between BMI and PFOS became
positive (Table 5). This suggests that BMI and maternal height might be proxies for other
variables, like GFR, and results in multivariate linear models should be interpreted with
caution.
Maternal socio-demographic and pregnancy related factors associated
with OC levels
The strong inverse associations between breastfeeding duration and all OC levels in the current
study are consistent with previous studies [50]. This is explained by excretion of OCs in the
breast milk, resulting in lower maternal serum levels of OCs and exposure to breastfeeding
children [51]. A recent review concluded that the benefits of breastfeeding far outweigh the
potential disadvantages, but argues to plea for further global source-directedmethods to reduce
human exposure to OCs [52].
The positive association betweenmaternal age and OC levels has been found in several
other cross-sectional studies [33, 53]. Age indicates whether the subject lived during periods
with higher exposure to OC levels. Based on longitudinal studies it has been shown that this
associationmay be considered a cohort effect related to historical emission patterns, rather
than age-dependentmetabolism or bioaccumulation [32].
The inverse relationships between pre-pregnancy BMI and serum levels of PCB153 and
t-NC levels may be explained by the dilution effects of OCs into adipose tissues [54]. However,
obesity can also prolong the half-lives of OCs whereby positive associations can be seen as well
[55]. Conversely, weight loss may lead to increased serum levels due to reduced storage capac-
ity in the adipose tissues. Similarly, weight gain may lead to decreased serum levels through
dilution of OCs into adipose tissue [56, 57]. The inverse association between BMI and OC lev-
els as found in our study, is supported by other cross-sectional studies that have observed vary-
ing associations with BMI depending on the OC under study [58].
The lower levels of PCB 118 among smokers at conception in adjusted analyses, were fur-
ther confirmed in additional analyses with smoking intensity both by number of cigarettes
smoked at conception and at early 2nd trimester, and by serum cotinine in 2nd trimester
(n = 88). These findings support the hypothesis that smoking cigarettes can enhance the
metabolism of PCB118, leading to reduced levels in serum. It has been speculated that cigarette
smoke can enhance the elimination rates of dioxins and dioxin-like PCBs, due to an induction
of CYP-enzymes [59]. Reasons for higher levels of β-HCH among smokers are unclear, but sev-
eral studies have found positive associations betweenOCs and smoking. This associationmay
be attributed to either the use of these pesticides on tobacco plants until they were banned in
the 1970s, or alternatively that cotinine influences the expression of CYP-enzymes that metab-
olize organochlorines [60].
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The positive associations between education level and serumOC levels might be explained
by different lifestyle patterns. More educated women with higher socio-economic status may
have different dietary patterns, such as increased consumption of fish. The linear relationship
between increased alcohol consumption and serumPCB153, t-NC and β-HCH levels might be
attributed to changes in fatty acid composition [61]. However, the overall alcohol consumption
was quite small, and other lifestyle factors might also have contributed to the differences in
levels.
Strengths and limitations
This study benefitted from a large sample size and detailed information about socio-demo-
graphic, lifestyle, pregnancy related factors, obstetric history and markers of pregnancy physi-
ology, that have been considered in only a few epidemiological studies. The serum samples
were taken in a narrow time frame in the early 2nd trimester (from week 13–20) to ensure com-
parability. To ensure that the results were not biased by the enrichment of mothers with SGA
offspring, we did stratum-weighted sensitivity analyses where weights were the inverse proba-
bility of selection [62]. We compared the results from the un-weighted and the weighted analy-
ses, and found that they were not substantially different (S1 Table). Women expecting their
first child were not included in the study, and this may have led to some selection bias, espe-
cially when considering excretion of EDCs through previous breastfeeding.We did not distin-
guish between exclusive and partial breastfeeding duration, and the lack of information about
the exclusive breastfeeding duration may have led to residual confounding and spurious associ-
ations between PFASs and OCs and factors associated with breastfeeding duration. However,
after birth we collected information about both exclusive and partial breastfeeding duration
after the current pregnancy, and found that both exclusive and total (exclusive + partial) breast-
feeding were highly correlated (r = 0.6). We also found total breastfeeding duration to be corre-
lated between pregnancies, suggesting that potential bias is limited. Moreover, breastfeeding
duration was recalled quite accurately 20 years after mothers gave birth in this study [63]. We
selected our cohort from an original SGA study with a high risk for SGA birth group that
included a high proportion of smokers. Although this may limit generalizability to other stud-
ies with fewer smokers, we were able to thoroughly study the relation between smoking status,
smoking intensity and serum cotinine levels and serumPFAS and OC levels in an otherwise
homogeneous population. To estimate GFR, we used an indirect method, based on a single-
point measurement of serum creatinine, as opposed to inulin clearance, which is the gold stan-
dard method [64]. Renal function drastically changes during pregnancy, because of hyper fil-
tration, systemic vasodilatation and plasma volume expansion, resulting in up to 60% increase
in GFR compared to values obtained before pregnancy [64]. Hence, indirect methodsmay be
biased. However, studies have shown that with increasing GFR, the differences between direct
and indirect methods stayed the same, and that bias was limited [64].
Conclusions
In summary, our study observedhigher maternal serumPFOA, PFOS and PCB 153 levels
among Swedish compared to Norwegianwomen. Severalmaternal factors including potentially
modifiable lifestyle factors, markers of pregnancy physiology and important factors related to
perinatal outcomes were associated with maternal serumEDC levels. Interestingly, we demon-
strated that long time since last breastfeeding periodwas associated with higher PFAS levels
and that maternal smoking showed a consistently negative association with PCB 118 in a dose-
dependent matter. Results from this study are particularly relevant to populations with still
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high PFAS and OC levels, for instance in some developing countries.Moreover, we can use this
knowledge about associated factors on new emerging EDCs with similar properties.
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